DNAprint Genomics (DNAG)

[worktoplay]

Theo...How about this for a financial theory.

According to the PR, this investment makes Biofrontera a $51 Million company, of which we'll own 52+-%. So we are going to be able to show an additional $25 Million on our balance sheet (52% of $26 Million - the current value of Biofrontera, and 52% of the $25 Million we have committed to provide.

It's kinda like taking $25 Million out of one pocket and putting it in the other...lol But in addition, you now will own 52% of a small molecule drug pipeline, and 52% of the development agreements Biofrontera has with companies like Shering.

Not bad for a company that only a year and a half ago had $10 grand in cash.

JMHO, of course.
W2P